Sign In
Buy TWST
$91.55
+0.220 (+0.241%)
At Close: Jul 31, 2026
These Analysts Boost Their Forecasts On Twist Bioscience After Q2 Results
02:36pm, Tuesday, 05'th May 2026
Twist Bioscience Corporation (NASDAQ:TWST) on Monday reported a loss for its fiscal 2026 second quarter.
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
08:00am, Tuesday, 05'th May 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and
Twist Bioscience Corporation (TWST) Q2 2026 Earnings Call Transcript
01:53pm, Monday, 04'th May 2026
Twist Bioscience Corporation (TWST) Q2 2026 Earnings Call Transcript
AI-Driven Demand Boosts Twist Bioscience Sales, But Loss Widens
01:46pm, Monday, 04'th May 2026
Twist Bioscience Corporation (NASDAQ:TWST) shares are down on Monday as the company reported its fiscal 2026 second-quarter financial results.
Twist Bioscience (TWST) Reports Q2 Loss, Beats Revenue Estimates
09:25am, Monday, 04'th May 2026
Twist Bioscience (TWST) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.66 per share a year ago.
Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences
07:20am, Monday, 04'th May 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today expanded its clonal genes portfolio with the early access l
Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results
07:15am, Monday, 04'th May 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the
Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026
08:00am, Tuesday, 21'st Apr 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it will issue its financial results for the
Adam Laponis Sells 2,597 Shares of Twist Bioscience (NASDAQ:TWST) Stock
04:27am, Wednesday, 15'th Apr 2026
Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) CFO Adam Laponis sold 2,597 shares of the company's stock in a transaction that occurred on Thursday, April 9th. The shares were sold at a
Twist Bioscience (NASDAQ:TWST) Director Sells $51,000.00 in Stock
04:48am, Monday, 06'th Apr 2026
Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) Director Melissa Starovasnik sold 1,000 shares of the firm's stock in a transaction dated Wednesday, April 1st. The stock was sold at an a
SG Americas Securities LLC Acquires 59,500 Shares of Twist Bioscience Corporation $TWST
04:47am, Sunday, 05'th Apr 2026
SG Americas Securities LLC lifted its holdings in Twist Bioscience Corporation (NASDAQ: TWST) by 350.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund
Twist Bioscience Corporation (NASDAQ:TWST) Receives Average Rating of “Moderate Buy” from Analysts
04:43am, Friday, 03'rd Apr 2026
Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the nine brokerages that are presently covering the company, Marketbeat.com r
Zenas BioPharma (NASDAQ:ZBIO) versus Twist Bioscience (NASDAQ:TWST) Critical Analysis
01:28am, Saturday, 28'th Mar 2026
Twist Bioscience (NASDAQ: TWST - Get Free Report) and Zenas BioPharma (NASDAQ: ZBIO - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses
Twist Bioscience Corporation (TWST) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
06:00pm, Tuesday, 10'th Mar 2026
Twist Bioscience Corporation (TWST) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Citigroup Inc. Cuts Position in Twist Bioscience Corporation $TWST
03:54am, Saturday, 07'th Mar 2026
Citigroup Inc. reduced its position in Twist Bioscience Corporation (NASDAQ: TWST) by 24.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exc
